AI Integration for 3D and Advanced Visualization Platforms

AI integration for 3D platforms like Sectra 3D, Philips IntelliSpace 3D, Intelerad 3D, and GE AW focuses on connecting inference services to the core visualization pipeline. The primary integration surfaces are the segmentation toolkit, measurement panel, and study navigation interface. Instead of forcing radiologists to exit their primary review environment, AI models are invoked via secure APIs to perform tasks like organ volumetry, vessel centerline extraction, or tumor segmentation directly on the loaded DICOM series. Results—typically returned as DICOM Segmentation objects (SEG) or Structured Reports (SR)—are ingested back into the platform's 3D scene graph, allowing for immediate rendering, editing, and quantitative analysis.

A production implementation wires a containerized AI inference service (hosted on-premises or in a compliant cloud like AWS HealthImaging) to the visualization platform's extension framework. For example, in Sectra 3D, this uses the Sectra Integration Platform (SIP) APIs; for GE AW, it leverages the AW Server SDK. The workflow is event-driven: a radiologist selects a series and clicks 'AI Segment Liver.' The platform sends a DICOMweb STOW-RS request with the study UID and series instance UID to a secure queue. The AI service processes the request, and the resulting segmentation mask is pushed back via WADO-RS. The platform then overlays the 3D mesh, populates the measurement table with volume, and updates the report draft with quantitative findings—all within 30-60 seconds.

Governance is critical. Each AI inference must be logged with a unique accession number, user ID, model version, and confidence scores for audit trails and MIPS reporting. Implement a human-in-the-loop review step before final sign-off; the AI-generated segmentation should be editable, with changes fed back to a model performance monitoring system. Rollout should start with a pilot cohort (e.g., surgical planning for hepatic resections) to validate workflow integration and clinical utility before scaling to other anatomies like pulmonary nodules or coronary arteries. This phased approach builds trust and ensures the AI tools augment, rather than disrupt, complex surgical and diagnostic planning workflows.

The integration connects to the 3D viewer's post-processing engine—the core module where radiologists perform manual segmentation, MPR, and volume rendering. For platforms like Sectra 3D, Philips IntelliSpace 3D, Intelerad 3D, or GE AW, this typically involves a custom plugin or extension that registers as a tool within the viewer's toolbar. The AI service, hosted on-premises or in a compliant cloud, exposes a secure REST API endpoint. When a radiologist selects an organ (e.g., liver, aorta) and clicks the AI tool, the viewer packages the current series UID and viewport parameters into a DICOMweb request, sending the relevant image slices to the inference endpoint.

The AI model returns a DICOM Segmentation object (SEG) or a DICOM Structured Report (SR) containing the 3D mask and quantitative measurements (volume, diameter, HU statistics). The viewer ingests this SEG/SR object and instantly overlays the AI-generated segmentation as a semi-transparent color map on the 3D volume. The radiologist can then toggle the overlay, edit the mask using native sculpting tools, and accept the AI-suggested measurements—which auto-populate into a structured report template. For surgical planning, the approved 3D model can be exported as an STL file directly to a 3D printer or surgical navigation system via integrated DICOM export pathways.

Governance is managed through the PACS Role-Based Access Control (RBAC) system. AI tools are permissioned to specific user roles (e.g., 'Body Imaging Radiologist', 'Cardiothoracic Surgeon') and clinical contexts (e.g., CT Abdomen studies). Every AI invocation is logged to an audit trail with the study ID, user, model version, and inference time. A human-in-the-loop review step is enforced before AI measurements are finalized in the report. For rollout, we recommend a phased deployment starting with a single high-volume use case (e.g., liver volumetry for transplant planning) within one department, using the existing PACS change management and training workflows to drive adoption.

Integrating AI segmentation and analysis tools into platforms like Sectra 3D, Philips IntelliSpace 3D, Intelerad 3D, or GE AW introduces new data flows and decision-support surfaces that must be governed. The primary integration points are the 3D post-processing engine and the clinical review workspace, where AI-generated segmentations (e.g., organs, vessels, tumors) are ingested as DICOM Segmentation objects or 3D mesh overlays. Security is paramount: all DICOM and PHI data must remain within the health system's secure network or a HIPAA-compliant cloud enclave, with AI inference calls authenticated via the platform's API gateway (e.g., Sectra's IDS7 API, Philips' HealthSuite APIs) and logged for audit. AI outputs should be stored as non-destructive overlays within the study series, preserving the original imaging data.

A phased rollout is critical for clinical adoption and risk management. Phase 1 typically involves a silent, parallel run where AI tools (e.g., liver segmentation, coronary artery analysis) process studies in the background, generating results that are visible only in a separate 'AI Findings' panel or require a manual toggle. This allows validation of AI performance against ground-truth manual segmentations without disrupting existing workflows. Phase 2 introduces assisted workflows, where the AI pre-populates a segmentation that the radiologist or surgeon can accept, modify, or reject with one click, directly within the 3D viewer. Phase 3 enables automated, protocol-driven AI activation—for instance, auto-running a CT angiography vessel analysis when a specific study protocol is detected—with clear indicators of AI involvement in the final report.

Governance is enforced through a centralized AI Orchestrator layer (often a separate microservice) that manages model versioning, routes studies to the appropriate AI based on modality and body part, and applies business rules (e.g., only run AI if patient consent is documented). Every AI interaction—from inference request to user acceptance of a result—generates an audit log tied to the study and user, creating a traceable chain of responsibility. This framework ensures AI augments, rather than automates, clinical judgment, keeping the specialist in control of the final diagnostic or surgical planning output while significantly accelerating measurement and modeling tasks from hours to minutes.